SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-05-001747
Filing Date
2005-03-30
Accepted
2005-03-30 16:24:29
Documents
9
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 ALNYLAM PHARMACEUTICALS, INC. - FORM 10-K b53309ape10vk.htm 10-K 1106693
2 EX-10.6 SUMMARY OF CASH COMPENSATION PAID TO DIRECTORS b53309apexv10w6.txt EX-10.6 1357
3 EX-21.1 SUBSIDIARIES OF THE REGISTRANT b53309apexv21w1.txt EX-21.1 594
4 EX-23.1 CONSENT OF PRICEWATERHOUSECOOPERS LLP b53309apexv23w1.txt EX-23.1 459
5 EX-31.1 SECTION 302 CERTIFICATION OF CEO b53309apexv31w1.txt EX-31.1 3577
6 EX-31.2 SECTION 302 CERTIFICATION OF CFO b53309apexv31w2.txt EX-31.2 3549
7 EX-32.1 SECTION 906 CERTIFICATION OF CEO b53309apexv32w1.txt EX-32.1 1223
8 EX-32.2 SECTION 906 CERTIFICATION OF CFO b53309apexv32w2.txt EX-32.2 1186
9 GRAPHIC b53309apb5330901.gif GRAPHIC 8619
  Complete submission text file 0000950135-05-001747.txt   1130005
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661
Type: 10-K | Act: 34 | File No.: 000-50743 | Film No.: 05714536
SIC: 2834 Pharmaceutical Preparations